Overview
April 13, 202 13:0 ET | Source: DelveInsight Business Research LLP New Delhi, INDIA New York, USA, April 13, 202 (GLOBE NEWSWIRE) - Acute Kidney Injury Pipeline to Progres with Novel and Emerging Drugs for Treatment, Analyzes DelveInsightAcute Kidney Injury takes place if the kidneys stop the filtration of the waste products from human blod. There are 25+ companies involved in the development of novel therapies for the treatment of acute kidney injury.
Key Information
The key players operating in the Acute Kidney Injury treatment market include Atox Bio, AM-Pharma, Angion Biomedica, Astelas Pharma, Guard therapeutics and several others.DelveInsight’s 'Acute Kidney Injury Pipeline Insight 202' report provides comprehensive global coverage of available, marketed, and pipeline Acute Kidney Injury therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Acute Kidney Injury pipeline domain.Key Takeaways from the Acute Kidney Injury Pipeline ReportRequest a sample and discover the recent breakthroughs hapening Acute Kidney Injury pipeline landscape in @ Acute Kidney Injury Pipeline OutlokThe Acute Kidney Injury pipeline report provides detailed profiles of pipeline asets, a comparative analysis of clinical and non-clinical stage Acute Kidney Injury products, inactive and dormant asets, a comprehensive asesment of driving and restraing factors, and an asesment of oportunities and risks in the Acute Kidney Injury pipeline landscape.Acute Kidney Injury OverviewAcute Kidney Injury (AKI), comonly known as Acute Renal Failure (ARF), is a condition characterized by progresive azotemia with or without oliguria over several hours or days.
Summary
Acute Kidney Injury is typicaly characterized as a suden los in renal function, clinicaly manifested as a reversible acute rise in nitrogen waste products evaluated by blod urea nitrogen and serum cr